Charles River Laboratories International Inc

8 de set. de 2026, 20:07 UTC

Charles River Laboratories International Inc shares declined during Tuesday's session, remaining near the lower end of their one-month trading range.

4 de set. de 2026, 19:16 UTC

Shares of Charles River Laboratories International Inc. are lower today amid notable volatility and broader market concerns about potential Federal Reserve interest rate hikes.

3 de set. de 2026, 23:01 UTC

Charles River Laboratories is higher in after-market trading, recovering from an initial dip and nearing the upper end of its one-month trading range.

2 de set. de 2026, 22:02 UTC

Shares of Charles River Laboratories are lower in after-market trading following a volatile session. Broader market dynamics may be influencing the asset's movement.

1 de set. de 2026, 22:06 UTC

Charles River Laboratories shares rose after-market, continuing to show resilience despite broader market pressure from rising bond yields and inflation expectations.

31 de ago. de 2026, 20:07 UTC

Charles River Laboratories is lower today amid broader market pressures from inflation concerns and potential interest rate hikes following the Jackson Hole Economic Symposium.

28 de ago. de 2026, 23:36 UTC

Charles River Laboratories is advancing in after-market trading, continuing its upward movement since Friday's close amid broader market dynamics. No specific news was identified.

27 de ago. de 2026, 22:01 UTC

Charles River Laboratories shares are higher in after-market hours, reflecting a positive trend despite earlier session volatility. Market factors remain under close observation.

26 de ago. de 2026, 19:16 UTC

Charles River Laboratories reports first-quarter revenue of $1.03 billion, missing estimates. Shares are lower amid sector declines and ongoing inflation concerns.

25 de ago. de 2026, 23:56 UTC

Charles River Laboratories shares are higher in after-market trading, maintaining a position near the upper end of their one-month range amid lower crude oil prices.

24 de ago. de 2026, 19:16 UTC

Charles River Laboratories is trading roughly flat amid a notable decline in Agilent Technologies. Market focus is on upcoming events, including a Federal Reserve speech.

21 de ago. de 2026, 23:01 UTC

Charles River Laboratories shares declined in after-market trading, amid broader market volatility tied to rising U.S. Treasury yields and inflation concerns.

20 de ago. de 2026, 19:41 UTC

Charles River Laboratories partners with Medigen to develop a multivalent enterovirus vaccine, supporting regulatory readiness and non-clinical studies. Shares are trading higher.

19 de ago. de 2026, 23:56 UTC

Charles River Laboratories shares are higher in after-market trading, reaching a notable increase since Wednesday's close and positioning near the upper end of its one-month range.

17 de ago. de 2026, 19:26 UTC

Charles River Laboratories shares are higher today, continuing an upward trend since Friday's close. The stock remains near the top of its one-month trading range.

14 de ago. de 2026, 19:46 UTC

Charles River Laboratories shares are lower amid broader market declines following a drop in U.S. retail sales, indicating potential weakening consumer demand.

13 de ago. de 2026, 19:52 UTC

Charles River Laboratories shares are lower today amid rising jobless claims and volatility, reflecting a decline since Wednesday's close.

12 de ago. de 2026, 20:51 UTC

Charles River Laboratories is higher in after-market trading, reflecting positive momentum despite no specific news. Broader market dynamics appear to support this resilience.

11 de ago. de 2026, 19:56 UTC

Charles River Laboratories International Inc. shares are trading higher today, maintaining a position above the 20-day moving average amid routine price movements.

10 de ago. de 2026, 19:16 UTC

Charles River Laboratories shares rise as TD Cowen and Mizuho raise price targets to $300 and $264, respectively. The stock shows notable strength since Friday.

7 de ago. de 2026, 19:51 UTC

Morgan Stanley raised its price target on Charles River Laboratories to $300, maintaining an Overweight rating as shares move higher since Thursday's close.

6 de ago. de 2026, 22:51 UTC

Shares of Charles River Laboratories International Inc. are lower in after-market trading, continuing a decline from Thursday's close despite being above its 20-day moving average.

5 de ago. de 2026, 23:56 UTC

Charles River Laboratories is higher in after-market hours, recovering from session lows. Broader market sentiment is affected by a disappointing ADP employment report.

4 de ago. de 2026, 19:16 UTC

Charles River Laboratories is rising amid positive momentum in the small-cap market, supported by a drop in crude oil prices that eases inflation concerns.

3 de ago. de 2026, 22:06 UTC

Charles River Laboratories shares are slightly higher in after-hours trading, supported by stronger-than-expected manufacturing data showing a rise in the PMI for July.

31 de jul. de 2026, 19:46 UTC

Charles River Laboratories reported first-quarter revenue of $1.02 billion and adjusted EPS of $2.06, but shares are lower amid broader market declines.

30 de jul. de 2026, 23:01 UTC

Shares of Charles River Laboratories are higher in after-market trading, reaching a peak above Thursday's close and remaining strong relative to recent trends.

29 de jul. de 2026, 19:18 UTC

Charles River Laboratories is lower today amid broader market declines and investor caution ahead of the Federal Reserve's monetary policy announcement.

28 de jul. de 2026, 18:02 UTC

Charles River Laboratories is trading higher today, continuing a strong rally since Monday. The stock remains above its 20-day moving average.

27 de jul. de 2026, 17:36 UTC

Charles River Laboratories is trading lower today, reflecting a decline since Friday. The company announced a collaboration with Arovella Therapeutics for GMP sequencing services.